Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-21-023768
Filing Date
2021-10-15
Accepted
2021-10-15 20:00:34
Documents
2
Period of Report
2021-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1357
2 dffn20211015_sec16.htm EX-24 8160
  Complete submission text file 0001437749-21-023768.txt   11197
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Issuer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SCYNEXIS, INC. 3501 C TRICENTER BOULEVARD DURHAM NC 27713
Business Address
Francois Eric (Reporting) CIK: 0001656125 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37942 | Film No.: 211327113